Clinical Trials Directory

Trials / Completed

CompletedNCT01927302

Neurobiology of Language Recovery in Aphasia: Natural History and Treatment-Induced Recovery

The Center for the Neurobiology of Language Recovery (CNLR)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Northwestern University · Academic / Other
Sex
All
Age
35 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the effects of treatment for specific language deficits in people with aphasia. In addition to language and cognitive measures, changes in brain function will also be gathered before and after the treatment is administered in order to track any changes resulting from receiving treatment.

Detailed description

Naming Impairments (Anomia): The labs of Dr. Swathi Kiran (Boston University) and Dr. David Caplan (Harvard University, Massachusetts General Hospital) will be studying language recovery in adults with anomia (naming impairments) following a stroke. Participants will receive treatment focusing on the semantic features of common objects (e.g., that birds can fly). The study will examine how naming and other language abilities change in response to treatment, as well as how the brain changes, as measured by magnetic resonance imaging (MRI) and other techniques. Spelling/Writing Impairments (Dysgraphia): At Johns Hopkins University, the lab of Dr. Brenda Rapp will investigate the neurobiology of language recovery in individuals with dysgraphia (spelling/writing impairments) resulting from a stroke. In this study, treatment will focus on improving spelling ability. The study will examine how spelling and other language abilities change in response to treatment, as well as how the brain changes, as measured by magnetic resonance imaging (MRI) and other techniques. Deficits in Sentence Comprehension \& Production: Dr. Cynthia Thompson's lab at Northwestern University will investigate language recovery in individuals with deficits in sentence production and comprehension. Treatment focuses on production and comprehension of complex sentences. At baseline (week 0) and after the treatment period (at week 12), participants take part in language, eye-tracking, and MRI testing, in order to learn how the processing of language, as well as brain function, changes as a result of treatment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTreatment Focusing on Naming ObjectsTreatment will be administered from week 0 until week 12.
BEHAVIORALTreatment Focusing on Improving Spelling AbilitiesTreatment will be administered from week 0 until week 12.
BEHAVIORALTreatment Focusing on Improving Sentence ProcessingTreatment will be administered from week 0 until week 12.
BEHAVIORALNo TreatmentNo treatment will be administered.

Timeline

Start date
2013-04-01
Primary completion
2019-03-27
Completion
2019-03-27
First posted
2013-08-22
Last updated
2021-08-11

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01927302. Inclusion in this directory is not an endorsement.